Biggest News Aggregation in the World
📰 Exclusive Option News

Exclusive Option News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Exclusive Option. Real-time updates on events, politics, business and more.

Biocytogen Pharmaceuticals Co., Ltd. Enters into Bispecific Antibody Drug Conjugate Agreement with Radiance Biopharma

Biocytogen Pharmaceuticals Co., Ltd. announced that it has entered into an Exclusive Option and License Agreement with Radiance Biopharma Inc. The agreement grants Radiance an option to license from...
Radiance Biopharma Inc Biocytogen Pharmaceuticals Beijing Co Ltd Biocytogen Pharmaceuticals Exclusive Option License Agreement Radiance Biopharma

Biocytogen Enters into Bispecific Antibody Drug Conjugate Agreement with Radiance Biopharma

BEIJING & BOSTON, January 08, 2024--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315), a global biotech company focusing on the discovery of novel antibody therapeutics, today announces that it has entered into an Exclusive Option and License Agreement with Radiance Biopharma Inc. ("Radiance"), a biotechnology company specializing in developing next generation Antibody Drug Conjugates.
San Francisco United States Haimen Jiangsu Yuelei Shen Marc Lippman Alphageneron Pharmaceuticals Inc
Source: yahoo.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Alphageneron Pharmaceuticals Signed Exclusive License Agreement With Multimmune GmbH For Natural Killer Cell Platform Therapy Worldwide

Alphageneron Pharmaceuticals Signed Exclusive License Agreement With Multimmune GmbH For Natural Killer Cell Platform Therapy Worldwide February 04, 2021 11:35 ET | Source: Alphageneron Pharmaceuticals Alphageneron Pharmaceuticals Cambridge, Massachusetts, UNITED STATES CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Alphageneron Pharmaceuticals, Inc., (Alphageneron) signed an Exclusive License Agreement with Multimmune GmbH, of Munich, Germany,...
United States United Kingdom Technische Universit Multimmune Gmb Graham Pockley Alphageneron Pharmaceuticals

Alphageneron Pharmaceuticals Signed Exclusive License Agreement With Multimmune GmbH For ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Alphageneron Pharmaceuticals Signed Exclusive License Agreement With Multimmune GmbH For ... Alphageneron PharmaceuticalsFebruary 4, 2021 GMT CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Alphageneron Pharmaceuticals, Inc., (Alphageneron) signed an Exclusive License Agreement with Multimmune GmbH, of Munich, Germany, (Multimmune) on October 1st, 2020, for its clinical stage autologous Natural Ki...
United States United Kingdom Technische Universit Multimmune Gmb Graham Pockley Alphageneron Pharmaceuticals
Source: apnews.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science